RecruitingPhase 3NCT07611110
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Sponsor: AstraZeneca
Phoenix, AZ · +27 more sites
Prostate Cancer clinical trials in Phoenix, AZ
16 recruiting prostate cancer studies with a site in Phoenix, AZ.
RecruitingPhase 3NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Sponsor: Pfizer
Chandler, AZ · Gilbert, AZ · Glendale, AZ · +36 more sites
RecruitingPhase 3NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Sponsor: Pfizer
Chandler, AZ · Gilbert, AZ · Glendale, AZ · +124 more sites
RecruitingPhase 3NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor: SWOG Cancer Research Network
Gilbert, AZ · Phoenix, AZ · +331 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +28 more sites
RecruitingPhase not listedNCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Sponsor: Alliance for Clinical Trials in Oncology
Kingman, AZ · Phoenix, AZ · +745 more sites
RecruitingPhase 1NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Sponsor: Exelixis
Phoenix, AZ · Tucson, AZ · +44 more sites
RecruitingPhase 3NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Sponsor: Clarity Pharmaceuticals Ltd
Phoenix, AZ · +28 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Phoenix, AZ · +340 more sites
RecruitingPhase 2NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Sponsor: Mayo Clinic
Phoenix, AZ · +2 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Phoenix, AZ · +373 more sites
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Gilbert, AZ · Phoenix, AZ · Tucson, AZ · +21 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Phoenix, AZ · +13 more sites
RecruitingPhase 2NCT05806515
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Sponsor: SWOG Cancer Research Network
Phoenix, AZ · +132 more sites
RecruitingNot applicableNCT04550845
Understanding of Genetics by Men at Risk for Prostate Cancer
Sponsor: Mayo Clinic
Phoenix, AZ · +2 more sites
Not yet recruitingPhase not listedNCT06194461
LTFU for All Cell and Gene Therapy Studies
Sponsor: AstraZeneca
Phoenix, AZ · +17 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.